Literature DB >> 7558133

Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.

S Marusić-Galesić1, P Walden.   

Abstract

Targeted disruption of the A beta-encoding gene of H2b mice abolishes major histocompatibility complex (MHC) class II expression and results in a failure to develop CD4+8- T cells. Besides this major effect, the lack of class II expression affects the level of T-cell receptor (TCR) and CD4 expression on differentiating thymocytes. Moreover, there is no class II-mediated negative selection of thymocytes. All this could result in TCR repertoire changes of the CD4-8+ T-cell subpopulation, which apparently develops normally in these mice. To test this hypothesis, the class II reactivity of CD4-8+ T cells from class II-deficient (class II0) mice was analysed. It was found that CD4-8+ T cells from class II0 but not from class II-expressing mice developed a significant level of cytotoxicity against class II-expressing target cells. These results demonstrate an influence of MHC class II molecules on the TCR repertoire of CD4-8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558133      PMCID: PMC1383918     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

Review 1.  The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.

Authors:  G Gammon; N Shastri; J Cogswell; S Wilbur; S Sadegh-Nasseri; U Krzych; A Miller; E Sercarz
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

2.  Development of CD4-CD8+ cytotoxic T cells requires interactions with class I MHC determinants.

Authors:  S Maruŝić-Galesić; D A Stephany; D L Longo; A M Kruisbeek
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

3.  Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.

Authors:  H Golding; T Mizuochi; S A McCarthy; C A Cleveland; A Singer
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

4.  Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.

Authors:  H Golding; A Singer
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

5.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

6.  H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex.

Authors:  J Klein; F Figueroa; C S David
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells.

Authors:  R Ceredig; J W Lowenthal; M Nabholz; H R MacDonald
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

8.  Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells.

Authors:  A M Kruisbeek; M J Fultz; S O Sharrow; A Singer; J J Mond
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

9.  Differentiation of Ia-reactive CD8+ murine T cells does not require Ia engagement. Implications for the role of CD4 and CD8 accessory molecules in T cell differentiation.

Authors:  T Mizuochi; L Tentori; S O Sharrow; A M Kruisbeek; A Singer
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

10.  Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.

Authors:  A M Kruisbeek; J J Mond; B J Fowlkes; J A Carmen; S Bridges; D L Longo
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.